KalVista Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: KALV
Share price (6/2/26): $26.94
Market cap (6/2/26): $1.434 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 97 pages Agreement and Plan of Merger Among: Kalvista Pharmaceuticals, Inc., a Delaware Corporation; Chiesi Farmaceutici S.P.A., an Italian Società Per Azioni; Skyline Merger Sub, Inc., a Delaware Corporation; and KalVista Pharmaceuticals Limited, a Private Limited Company Organized Under the Laws of England and Wales Dated as of April 29, 2026

from 8-K 83 pages Share Purchase Agreement by and Among Carbylan Therapeutics, Inc., the Shareholders of KalVista Pharmaceuticals Ltd., KalVista Pharmaceuticals Ltd. and the Seller Representative Dated as of June 15, 2016

from DEFA14A 4 pages Form of Lock-Up Agreement

from 8-K 4 pages Form of Lock-Up Agreement

from 8-K 20 pages Support Agreement

from DEFA14A 20 pages Support Agreement

from 8-K 83 pages Share Purchase Agreement by and Among Carbylan Therapeutics, Inc., the Shareholders of KalVista Pharmaceuticals Ltd., KalVista Pharmaceuticals Ltd. and the Seller Representative Dated as of June 15, 2016

from DEFA14A 83 pages Share Purchase Agreement by and Among Carbylan Therapeutics, Inc., the Shareholders of KalVista Pharmaceuticals Ltd., KalVista Pharmaceuticals Ltd. and the Seller Representative Dated as of June 15, 2016